MedX Logo
 


About Us > Press Releases


MedX Health Corp. is a medical technology company that develops, manufactures and distributes unique phototherapy devices that are FDA and Health Canada cleared.

Media Contact:
Steve Guillen, CEO
(905) 670-4428
Email: guillen@medxhealth.com

MDX STOCK QUOTE
SEDAR PUBLIC FILINGS



May 28, 2013

MEDX HEALTH CORP. RESULTS FOR THE FIRST QUARTER OF FISCAL 2013


May 15, 2013

Audited Consolidated Financial Statements For the Years Ended December 31, 2012 and 2011


May 15, 2013

MEDX HEALTH CORP. ANNOUNCES RESULTS FOR THE YEAR ENDED DECEMBER 31, 2012 AND LOOKS FORWARD WITH CONFIDENCE TO FISCAL 2013


May 15, 2013

FORM 52-109FV1 CERTIFICATION OF ANNUAL FILINGS VENTURE ISSUER BASIC CERTIFICATE


May 15, 2013

Management Discussion and Analysis for the Year ended December 31, 2012


May 15, 2013

FORM 52-109FV1 CERTIFICATION OF ANNUAL FILINGS VENTURE ISSUER BASIC CERTIFICATE


April 12, 2013

MedX announces anticipated delay in Annual Financial Results for the year ended December 31, 2012


April 12, 2013

MATERIAL CHANGE REPORT FORM 51-102F3


April 5, 2013

MedX Names Louie Canitano as President and Chief Operating Officer


March 7, 2013

UNAWARE OF ANY MATERIAL CHANGE


December 5, 2012

MEDX HEALTH CORP. ANNOUNCES CLOSING OF DEBT SETTLEMENT AGREEMENTS


December 5, 2012

MEDX HEALTH CORP. ENTERS INTO ADVISORY AGREEMENT WITH BYRON CAPITAL MARKETS


November 28, 2012

MEDX HEALTH CORP. ANNOUNCES GRANT OF INCENTIVE STOCK OPTIONS


May 17, 2012

MUNKNEE.COM: This Skin Cancer Detection Device Could Be a Great Investment in Your Health – and Your Wealth


May 16, 2012

MoleMate “Optical Biopsy” Poised to Improve The Quality of Care for Patients with Moles

MedX Survey Confirms Almost 90% of Moles Biopsied Are Benign


May 7, 2012

MedX Reports Year End Financials and Record Fourth Quarter Sales

Skin Cancer Detection Product, MoleMate, Accounts for Over 60% of Q4 Revenues


April 19, 2012

MedX Granted Additional US and Australian Patents For the Use of Light to Visualize Structures Within Skin

MedX Has a Broad International Portfolio of Granted Patents (17) and Many Patents Pending (23) - Patented Technology Applicable In Burn and Wound Care Markets


April 12, 2012

MedX Committed to Skin Cancer Patient Awareness

Questionnaire to Reveal Area of Cost Savings Due to the High Percentage of Moles Biopsied/Removed that are Benign


April 2, 2012

MedX Health Announces Non-Brokered Private Placement

$1,000,000 Dollar Growth Financing to Accelerate the Global Expansion of MoleMate Skin Cancer Imaging Sales and Marketing Programs


March 23, 2012

Skin Cancer Imaging with MoleMate Featured at American Academy of Dermatology Meeting

Broad Attendance by International and North American Dermatologists


March 20, 2012

MedX Health Corp. Enters China – One of the World’s Largest and Fastest Growing Medical Device Markets

MedX Receives First Order From Beijing Tagene Medical Co., Ltd.


March 9, 2012

New Video Examines the Improvement In the Quality of Care of Patients For the Early Detection of Skin Cancer With MoleMate

Ronald H. Falcon, MD, FAAD and his patients discuss the benefits of non-invasive mole exams with a MoleMate siascope


March 5, 2012

Skin Cancer Imaging with MoleMate™ Accelerates New Revenue Growth Strategy Via Entry Into Multiple Hundred Million Dollar Markets and On-Line Services

Expanded discussion at the Annual Shareholders’ Meeting Scheduled for March 13, 2012, 4 p.m. in Toronto at The National Club


February 29, 2012

Senior Management Agree to Debt Settlement Of $1.3 Million at Significant Prices Over Market

Key Officers of MedX Health Agree to Debt Settlement of 1/3 at $0.25, 1/3 at $0.50, and 1/3 at $0.75


February 8, 2012

Health Canada Approves Skin Cancer Imaging System, MoleMate™

Technology allows physicians to ‘See More’ and reduce the number of painful and costly biopsies performed


November 14, 2011

MedX Announces ScreenCancer AS

Expands Use of MoleMate™ Technology Via Cancer Screening Clinics in UAE and Australia


September 21, 2011

Innovative Skin Imaging System, MoleMate™ FDA Approved and Now Available in the US


June 14, 2011

MedX Health Announces Agreement for Acquisition of Worldwide Assets of Innovative Skin Imaging System, MoleMate™


January 12, 2011

MedX Health Announces US Agreement for Innovative Skin Analysis System, MoleMate™

Additional Updates On New Initiatives, and Amendment to LOI on H’andy Sana 211 Provided at Upcoming AGM scheduled for Thursday, January 27th


September 30, 2010

MedX Health Corp.’s RJ-Laser Veterinary Products Selected by Vet Novations Canada

Details and updates on new partnerships at AGM Now scheduled for November 17th, 2010


August 13, 2010

MedX Health Corporation Updates Shareholders Meeting Date and Re-Structuring Plans

Shares for debt and a private placement to support launch of new telemedicine product the H’andy sana 211 cell phone with integrated ECG capability


July 27, 2010

MedX Health Corporation Announces Annual General & Special Meeting and Plans to Issue Shares

Shares for debt and a private placement


July 26, 2010

MedX Health Corporation Announces Discussions For the North American Marketing Rights to Cardiology Telemedicine Technology

Discussions Underway with Medical Marketing Berlin for Rights To the H’andy sana 211 cell phone with integrated ECG capability


June 4, 2010

MedX Health Corp. Provides Default Status Report


March 23, 2010

MedX Health Corp Acquires RJ-Laser Canadian Operations

MedX Acquires Approved Products for Veterinary and Dermatology
MedX Strengthens Product Mix Within Existing Rehab/Chiropractic, Dental and Acupuncture Markets


March 15, 2010

MedX Health Corporation Issues Shares


January 21, 2010

MedX Health Corp Announces Date For Annual Meeting


October 28, 2009

MedX Health Signs Master Distributor Agreement with Medical Marketing Berlin GmbH (MMB)

MedX with new partner to present at Medica November 18-21, Dusseldorf, Germany

MedX unterzeichnet Rahmenvertriebsvertrag mit Medical Marketing Berlin GmbH (MMB)


August 20, 2009

MedX Health Corp Reports Second Quarter 2009 Financial Results


July 14, 2009

MedX Health Corp. Announces Private Placement

Formation of MedX Health Financing Limited Partnership - Maximum subscription: $2,500,000


May 27, 2009

MedX Health Corp Reports First Quarter 2009 Financial Results

36% Gain in Q1 2009 Compared to Q4 2008


April 22, 2009

MedX Health Establishes European Distribution Center

New Director of European Sales, Frank Raymakers, to Oversee Unit


April 16, 2009

MedX Health Corp Reports Year End 2008 Financial Results

49% Gain In Last Half of 2008 Compared To Last Half of 2007


March 4, 2009

MedX Health Receives CE Mark for Laser & Light Products

MedX Expects Accelerated Revenue Growth From World's Largest Economy


February 23, 2009

MedX Health Announces Patent Allowance for Use of Laser and Light Probe for Bone Healing

Notice of Allowance Covers Laser and Light Therapy Apparatus and Method for Bone Healing, Bone Growth Stimulation and Bone Cartilage Regeneration


January 22, 2009

MedX Health Announces Initiation of Laser Acupuncture Study for Controlling Addiction

North American Trial will Determine Effectiveness of Laser Acupuncture in Reducing Addiction to Nicotine, Alcohol and Drugs


November 17, 2008

MedX® Announces Manufacturing and Distribution Agreement with US-based Medical Device Company Naimco/Rich-Mar

Med X's Low Level Laser Technology Will Enhance Benefits of Naimco/Rich-Mar E-Stim and Ultrasound Devices While Gaining Greater Access to International Markets


November 10, 2008

MedX® Health Corp Reports Third Quarter 2008 Financial Results

Results for the three months ended September 30, 2008


October 8, 2008

Senior Executives to Buy Back Shares of MedX® Stock

Chairman and CEO Combine to Buy Back Shares from Estate of Founder


October 6, 2008

MedX® Receives FDA Clearance for OralaseT

Technology4Medicine to have exclusive U.S. distribution rights for Oralase in the U.S.

October 1, 2008

Steve Guillen on MedX Health Corporation: Lighting the Way

American Executive - Corporate Spotlight

August 22, 2008

MedX® Announces Financial Results for Q2 of 2008

MedX remains on track in commitment to expand products and services internationally

August 05, 2008

MedX® Announces Private Financing

MedX to Use Proceeds to Expand Commercialization Plans

July 16, 2008

MedX® Announces Change in Financing

Funding to Support US and International Distributor Agreements Remains Priority

July 15, 2008

Technology4Medicine becomes Exclusive U.S. Dental Distributor

Technology4Medicine to have exclusive U.S. distribution rights for MedX lasers in the dental, dermatology, plastic surgery and anti-aging markets

June 27, 2008

MedX® Announces Steve Guillen promoted to CEO

Appointment Announced during Annual General Meeting of Shareholders

June 25, 2008

MedX® AGM Meeting by Steve Guillen

Steve Guillen presented his views of MedX at the AGM Meeting in this slide presentation

June 05, 2008

MedX® Announces Positive Results From Low-Level Laser Therapy Study in Wound Healing

Research results presented at the World Union of Wound Healing Societies Congress 2008 in Toronto

May 28, 2008

MedX® Launches Products in International Markets

Seasoned health-care executive joins MedX as Director of International Business Development

May 20, 2008

MedX® Files Photobandage Patent

MedX Health Corp. Files U.S. Patent Application for "PhotobandageT" Light Therapy for the Wound-Care Market

MedX Health Corp. Announces Private Placement
May 13, 2008

Proceeds to augment recent public offering, fund growth program

MedX 2007 Financial Results
April 30, 2008

MedX Health Corp. Announces Year End Financial Results

MedX Health Corp. Welcomes Steve Guillen
April 1, 2008

MedX Health Corp. Board Appoints Steve Guillen as President and Director

MedX Retains Taddle Creek Capital
February 27, 2008

MedX Health Corp. Retains Taddle Creek Capital to Provide Advisory Services

MedX Health Corp. Listed on TSX Venture Exchange
February 12, 2008

MedX Health Corp. Shares begin trading on the TSX Venture Exchange with stock symbol 'MDX'

MedX Public Offering Completed
January 31, 2008

MedX Health Corp. has completed the Offering of Units to investors in British Columbia, Alberta, Manitoba and Ontario.

MedX Oralase Dental Product Launch Update
November 9, 2007

Laser Light Canada features Oralase Portable Laser in Canadian Dental Seminar Series

MedX Introduces Oralase Dental Product
November 3, 2007

MedX test markets Oralase Portable Laser Dental Product in Canada







Copyright© 2010 MedX Health™ 220 Superior Blvd., Mississauga, Ontario Canada L5T 2L2